EN
HI
Hikal Share price
HIKAL
212.84
5.14 (-2.36%)NSE
BSE
Last updated on 12 Aug, 2026 | 15:57 IST
Hikal share price chart
Hikal Share Key Metrics
Volume
2.43 L
Market Cap
2624.33 CR
LTQ@LTP
28@212.84
ATP
213.76
Var Margin
21.45 %
Circuit Range
174.39-261.57
Delivery %
52.41 %
Value
5.19 CR
ASM/GSM
No
Market Lot
1
Summary
HIKAL stock price is ₹212.84 as of 12 Aug, 2026. The stock intraday movement has stayed between ₹211.10 and ₹218.35, while Hikal share price 52 week high low is ₹146.25 & ₹307.65.
In terms of trading activity, HIKAL share price has recorded a volume of 2,42,629 shares. The Hikal has a market cap of ₹123300750. The stock’s Average Traded Price (ATP) stands at ₹213.76, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 28 @ ₹212.84.
The Hikal upper circuit limit is ₹261.57 & The Hikal lower circuit limit is ₹174.39, with a Value of ₹5.19 CR. The Delivery Percentage for the day is 52.41%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Hikal Resistance and Support
Pivot 218.81
Resistance
First Resistance
223.4
Second Resistance
228.82
Third Resistance
233.41
Support
First Support
213.39
Second Support
208.8
Third Support
203.38
Hikal Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
68.85%
Mutual Fund
5.92%
Insurance
0%
Foreign Institutional Investors
0.98%
Domestic Institutional Investors
1.33%
Retail
22.93%
Others
-0.01%
Total Promoters
MAR '26
68.85%
JUN '26
68.85%
Hikal Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-27 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-04 | Quarterly Results & Interim Dividend |
| 2024-11-12 | Quarterly Results |
| 2024-08-01 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-02-17 | 2026-02-17 | View More |
Hikal News
Hikal Ltd - 524735 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Hikal reported Q1 FY27 results with revenue at Rs. 403 cr, a 6.05% increase YoY. The company significantly reduced its net loss to Rs. 7 cr from Rs. 22 cr in Q1 FY26, driven by a 48% jump in EBITDA to Rs. 37 cr.
Aug 06 2026 16:38:17
Hikal Ltd - 524735 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026
Hikal's board approved Q1 FY27 cons. financial results with revenue at ₹402.8 crores, up 5.9% YoY, and net loss reduced to ₹7.4 crores from ₹22.4 crores YoY. The company also reported an ₹8.9 crore exceptional item benefit from salary component restructuring.
Aug 06 2026 14:54:41
Hikal Ltd - 524735 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Quarter Ended June 30, 2026
Hikal's Board of Directors will convene on August 06, 2026, to consider and approve the financial results for Q1 FY27. This meeting will review both standalone and consolidated unaudited figures for the quarter ended June 30, 2026.
Jul 30 2026 17:30:43
Hikal Ltd - 524735 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Hikal Ltd has received the EcoVadis Gold Medal for Sustainability Excellence, ranking among the top 5% of over 175,000 globally assessed companies. This recognition enhances credibility with global customers and investors.
Jul 29 2026 17:25:36
Read More
Hikal Management
| Name | Position |
|---|---|
| Rajasekhar Reddy | Company Secretary & Compliance Officer |
| Jai Hiremath | Chairman |
Hikal Similar Stocks
Advanced Enzyme Technologies Ltd.
301.65
3.35 (1.12%)
Kwality Pharmaceuticals Ltd.
3313.80
3.30 (0.10%)
Dishman Carbogen Amcis Ltd.
191.15
-2.28 (1.18%)
Beta Drugs Ltd.
2559.00
-109.30 (4.10%)
Sai Parenteral's Ltd.
552.40
-21.10 (3.68%)
Solara Active Pharma Sciences Ltd.
505.60
-3.10 (0.61%)
Panacea Biotec Ltd.
399.85
-2.35 (0.58%)
Dr Agarwals Eye Hospital Ltd.
5311.50
-3.00 (0.06%)
NGL Fine-Chem Ltd.
3409.00
-38.70 (1.12%)
Hikal FAQs
The Buying Price of Hikal share is 212.84 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Hikal stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Hikal, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Hikal shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Hikal shares is 2.26. Useful to assess the stock's value relative to its book value.
To assess Hikal’s valuation compare Sector P/E, P/B which are 65.02 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Hikal is 2624.33 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Hikal share price is 307.65 & 146.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Hikal belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in HIKAL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC